Tagged: deal

0

Johnson & Johnson to acquire Actelion in $30 billion deal

U.S. healthcare giant Johnson & Johnson will acquire Swiss biotech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion’s research and development pipeline, the companies said on Thursday. The acquisition...